Roham Zamanian

Professor of Medicine (Pulmonary and Critical Care Medicine)

Bio

Dr. Roham Zamanian specializes in the treatment of pulmonary hypertension, right heart failure, and pulmonary embolism. He has more than 2 decades of sub-specialty experience in pulmonary vascular diseases. Dr. Zamanian is considered one of the leading international experts in clinical trials and drug development for pulmonary hypertension.

Clinical Focus

Pulmonary Hypertension
pulmonary vascular diseases
pulmonary embolism
right heart failure
Pulmonology (Lung) and Critical Care
Pulmonary Disease

Academic Appointments

Professor - University Medical Line, Medicine - Pulmonary, Allergy & Critical Care Medicine
Member, Cardiovascular Institute
Member, Wu Tsai Human Performance Alliance

Administrative Appointments

Associate Director, Vera Moulton Wall Center for Pulmonary Vascular Disease (2024 - Present)
Director, Adult Pulmonary Hypertension Service, Vera Moulton Wall Center for Pulmonary Vascular Disease (2007 - Present)
Clinical Director, VMWC Pulmonary Hypertension Database, Vera Moulton Wall Center for Pulmonary Vascular Disease (2006 - Present)

Honors & Awards

Howard Huges Summer Fellowship, Harvard School of Medicine (1992 & 1993)
Ralph Waldo Gerard Award for Outstanding Researcher, University of California, Irvine School of Biological Sciences (1994)
Excellence in Research Award, University of California, Irvine School of Biological Sciences (1995)
Case Presentation Award, ACCP - Chest 2000 (2000)
Resident Research Presentation Award, Univ of Calif, Irvine Medical Center - Dept of Medicine (2001)
Fellow of the Year, Univ of Califronia, Irvine Medical Center (2002-2003)
Young Investigator Career Development Award, Entelligence Actelion Young Investigators Program (2006-2007)
Faculty Teaching Award, Dept of Medicine, Stanford (2007)
Fellow of the American College of Chest Physicians, American College of Chest Physicians (2008)

Boards, Advisory Committees, Professional Organizations

Scientific Advisory Board, PHaware (2016 - Present)

Professional Education

Medical Education: University of California at Irvine School of Medicine (1999) CA
Fellowship: Stanford University School of Medicine (2005) CA
Board Certification: American Board of Internal Medicine, Pulmonary Disease (2024)
Fellowship: Stanford University Pulmonary and Critical Care Fellowship (2006) CA
Fellowship: University of Irvine Medical Center (2003) CA
Residency: University of Irvine Medical Center (2002) CA
Internship: University of Irvine Medical Center (2000) CA
Super-Fellowship, Stanford University, Pulmonary Vascular Disease (2006)
Fellowship, Stanford University, Pulmonary & Critical Care (2005)
Fellowship, UCI Medical Center, Pulmonary & Critical Care (2003)
Residency, UCI Medical Center, Internal Medicine (2002)
MD, University of California, Irvine, Medicine (1999)
BS, University of California, Irvine, Biological Sciences (1994)

Community and International Work

Blue Lips Foundation

Topic

Partnering Organization(s)

Populations Served

Location

US

Ongoing Project

true

Opportunities for Student Involvement

false
PHaware

Topic

Partnering Organization(s)

Populations Served

Pulmonary Hypertension Patients

Location

International

Ongoing Project

true

Opportunities for Student Involvement

false
Member PHA Scientific Leadership Council

Topic

Partnering Organization(s)

Pulmonary Hypertension Association

Populations Served

Location

International

Ongoing Project

false

Opportunities for Student Involvement

false

Patents

Edda Spiekerkoetter, Marlene Rabinovitch, Roham Zamanian. "United StatesFK506 for treatment of PAH", Leland Stanford Junior University

Contact

Academic roham.zamanian@stanford.edu

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Pulmonary and Critical Care 300 Pasteur Dr A251 MC 5221 Stanford CA 94305 Tel: (650) 723-6381 Fax: (650) 725-5489

Additional Clinical Info

Stanford Health Care

Current Research and Scholarly Interests

1. Development and evaluation of prognostic and diagnostic integral biomarkers in PAH.

2. Prevalence and Treatment of Insulin Resistance in PAH.

3. Role of inflammation and proteomic signature in PAH

4. Development of novel therapeutics (bench to bedside) including FK506 & Elastase Inhibition in PAH.

5. Assessment of Vasoreactivity (gain and loss) in pulmonary arterial hypertension

6. Assessment of microvascular function in PAH.

2025-26 Courses

Independent Studies
- Directed Reading in Medicine
  MED 299 (Aut, Win, Spr, Sum)
- Early Clinical Experience in Medicine
  MED 280 (Aut, Win, Spr, Sum)
- Graduate Research
  MED 399 (Aut, Win, Spr, Sum)
- Medical Scholars Research
  MED 370 (Aut, Win, Spr, Sum)
- Undergraduate Research
  MED 199 (Aut, Win, Spr, Sum)

Stanford Advisees

Postdoctoral Faculty Sponsor
Or Bruck

Find a doctor

Clinics & Services

Research Resources

Professional Training

Education Resources

Roham Zamanian

Professor of Medicine (Pulmonary and Critical Care Medicine)

Topic

Partnering Organization(s)

Populations Served

Location

Ongoing Project

Opportunities for Student Involvement

Topic

Partnering Organization(s)

Populations Served

Location

Ongoing Project

Opportunities for Student Involvement

Topic

Partnering Organization(s)

Populations Served

Location

Ongoing Project

Opportunities for Student Involvement

2025-26 Courses

Stanford Advisees